[{"indications": "Indications\u00a0primary and secondary carnitine deficiency", "name": "CARNITINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.8 Metabolic disorders", "9.8.1 Drugs used in metabolic disorders", "Carnitine deficiency", "CARNITINE"], "cautions": "Cautions\u00a0diabetes mellitus; monitoring of free and acyl carnitine in blood\r\nand urine recommended", "side-effects": "Side-effects\u00a0nausea, vomiting, abdominal pain, diarrhoea, body\r\nodour; side-effects may be dose-related\u2014monitor tolerance during first\r\nweek and after any dose increase", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/27711.htm", "doses": ["Primary deficiency, by mouth, up to 200\u00a0mg/kg\r\ndaily in 2\u20134 divided doses; usual max. 3\u00a0g daily; by intravenous\r\ninjection over 2\u20133 minutes, up to 100\u00a0mg/kg daily in 2\u20134 divided doses", "Secondary deficiency, by intravenous injection over 2\u20133 minutes, 20\u00a0mg/kg after each dialysis session (dosage adjusted\r\naccording to plasma-carnitine concentration); maintenance\r\n(if benefit gained from first intravenous course), by mouth, 1\u00a0g daily"], "pregnancy": "Pregnancy\u00a0appropriate to use; no evidence of teratogenicity\r\nin animal studies"}]